Drugs Using for COVID-19 Treatment: A Narrative Review

Javad Boskabadi; Zahra Askari; Hamideh  Abbaspour-kasgari

doi:10.18502/tbsrj.v3i1.6174

Javad Boskabadi Department of Clinical Pharmacy, Faculty of pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Zahra Askari Department of Toxicology, Faculty of pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Hamideh Abbaspour-kasgari Department of Clinical Pharmacy, Faculty of pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

DOI: https://doi.org/10.18502/tbsrj.v3i1.6174

Keywords: Antiviral Agents, Covid-19, Drug Treatment, Global Pandemic

Abstract

The Novel Coronavirus Disease 2019 (COVID-19) was identified firstly in CHINA. Manifestation of this disease can be in wide range from asymptomatic to severe critical disease. All gender and ages are at risk for Covid-19 infection in other hand, COVID-19 was known as respiratory infectious disease but this infection may present with other organ injury.
Although effective drug for COVID-19 treatment not approved but some antiviral agents and immune modulating treatments may be beneficial. The aim of this study is to evaluate the medications using for treatment patients with Covid-19 infection. Although effective treatment not approved for covid-19 but Remdesivir, as antiviral agent, and dexamethasone are recommended for use in hospitalized patients.